| |
| |
|
| Insider
Information: |
Shak Steven |
| Relationship: |
Chief Scientific Officer |
| City: |
Redwood City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
339,671 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$21,548,728 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
339,671 |
|
|
| Total
Value |
$21,548,728 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Genomic Health Inc |
GHDX |
Chief Scientific Officer |
2019-01-29 |
339,671 |
2019-11-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
170 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 7 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GHDX |
Genomic Health Inc |
EVP of R&D |
• – – |
2015-02-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,432) |
320,116 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
EVP of R&D |
• – – |
2016-02-15 |
4 |
D |
$26.53 |
$74,151 |
D/D |
(2,795) |
318,073 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
EVP of R&D |
• – – |
2016-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
8,310 |
326,383 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
EVP of R&D & CMO |
• – – |
2012-08-20 |
4 |
AS |
$34.99 |
$174,940 |
D/D |
(5,000) |
353,768 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
EVP of R&D & CMO |
• – – |
2012-09-18 |
4 |
AS |
$33.76 |
$168,800 |
D/D |
(5,000) |
348,768 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
EVP of R&D & CMO |
• – – |
2012-10-16 |
4 |
AS |
$34.12 |
$176,254 |
D/D |
(5,000) |
343,768 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
EVP of R&D & CMO |
• – – |
2012-11-20 |
4 |
AS |
$26.91 |
$134,710 |
D/D |
(5,000) |
338,768 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
EVP of R&D & CMO |
• – – |
2012-12-18 |
4 |
AS |
$27.74 |
$138,721 |
D/D |
(5,000) |
333,768 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
EVP of R&D & CMO |
• – – |
2013-02-15 |
4 |
D |
$28.77 |
$39,933 |
D/D |
(1,388) |
332,380 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
EVP of R&D & CMO |
• – – |
2013-05-21 |
4 |
AS |
$37.19 |
$185,957 |
D/D |
(5,000) |
327,380 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
EVP of R&D & CMO |
• – – |
2013-06-18 |
4 |
AS |
$32.72 |
$167,605 |
D/D |
(5,000) |
323,283 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
EVP of R&D & CMO |
• – – |
2013-07-23 |
4 |
AS |
$35.33 |
$176,670 |
D/D |
(5,000) |
318,283 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
EVP of R&D & CMO |
• – – |
2013-07-25 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
323,283 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
EVP of R&D & CMO |
• – – |
2013-08-14 |
4 |
AS |
$32.98 |
$164,906 |
D/D |
(5,000) |
318,283 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
EVP of R&D & CMO |
• – – |
2013-09-18 |
4 |
AS |
$33.73 |
$168,629 |
D/D |
(5,000) |
313,283 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
EVP of R&D & CMO |
• – – |
2013-10-15 |
4 |
AS |
$29.67 |
$148,341 |
D/D |
(5,000) |
308,283 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
EVP of R&D & CMO |
• – – |
2013-12-16 |
4 |
OE |
$2.88 |
$20,160 |
D/D |
7,000 |
315,283 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
EVP of R&D & CMO |
• – – |
2013-12-16 |
4 |
AS |
$29.91 |
$209,350 |
D/D |
(7,000) |
308,283 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
EVP of R&D & CMO |
• – – |
2013-12-17 |
4 |
OE |
$2.88 |
$20,160 |
D/D |
7,000 |
315,283 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
EVP of R&D & CMO |
• – – |
2013-12-17 |
4 |
AS |
$29.24 |
$204,671 |
D/D |
(7,000) |
308,283 |
0 |
- |
|
170 Records found
|
|
Page 7 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
